Recent Updates
Recently added Catalysts
PRTA

Prothena to Participate in Upcoming March Healthcare Conferences

Key Takeaway: DUBLIN, Ireland, March 05, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, today announced that members of its senior management team will present and participate in the following March investor conferences: Barclays Global

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
8.1%
average across 2 past catalysts
Cash runway
~34 mo
Minimal dilution risk
Lead asset
PRX003
Phase 1 · Psoriasis

Full Press Release Details

DUBLIN, Ireland, March 05, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, today announced that members of its senior management team will present and participate in the following March investor conferences:
Barclays Global Healthcare Conference on March 12, 2019 at 8:30 AM ET in Miami, FL
Oppenheimer’s 29th Annual Healthcare Conference on March 20, 2019 at 1:35 PM ET in New York, NY
A live webcast of the company presentation can be accessed through the investor relations section of the Company's website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company's website for at least 90 days following the presentation date.
Media and Investor Contact:
Last updated: Mar 5, 2019